V

Veracyte
D

VCYT

40.900
USD
1.84
(4.71%)
مغلق
حجم التداول
0
الربح لكل سهم
1
العائد الربحي
-
P/E
-315
حجم السوق
3,169,734,826
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    NEOUSD
    NEOUSD
    -0.165
    (-1.15%)
    13.996 USD
    C
    CDNA
    0.120
    (0.58%)
    20.660 USD
    E
    EXAS
    3.290
    (5.87%)
    59.370 USD
    F
    FGEN
    0.05360
    (15.16%)
    0.40720 USD
    G
    GH
    0.570
    (1.83%)
    31.670 USD
    ILMN
    ILMN
    2.030
    (1.52%)
    135.930 USD
    N
    NEO
    0.025
    (0.15%)
    16.405 USD
    R
    RGEN
    -2.045
    (-1.39%)
    144.570 USD
    T
    TDOC
    0.48000
    (5.35%)
    9.45000 USD
    T
    TNDM
    2.640
    (7.94%)
    35.900 USD
    V
    VEEV
    4.360
    (1.98%)
    224.170 USD
    المزيد
الأخبار

العنوان: Veracyte

القطاع: Healthcare
الصناعة: Diagnostics & Research
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others.